A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Public ClinicalTrials.gov record NCT06066138. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Feasibility Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Study identification
- NCT ID
- NCT06066138
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 30 participants
Conditions and interventions
Conditions
- Locally Advanced Alveolar Soft Part Sarcoma
- Locally Advanced Hepatocellular Carcinoma
- Locally Advanced Melanoma
- Locally Advanced Non Small Cell Lung Cancer
- Locally Advanced Small Cell Lung Cancer
- Metastatic Alveolar Soft Part Sarcoma
- Metastatic Hepatocellular Carcinoma
- Metastatic Melanoma
- Metastatic Non Small Cell Lung Cancer
- Metastatic Small Cell Lung Cancer
Interventions
- Atezolizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2025
- Primary completion
- Jan 30, 2027
- Completion
- Jan 30, 2028
- Last update posted
- Apr 19, 2026
2025 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06066138, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06066138 live on ClinicalTrials.gov.